Value of venous thromboembolism prophylaxis by enoxaparin with anti-factor Xa trough concentration monitoring in surgical care
Saved in:
Main Authors: | Seeba Zachariah (Author), Maitha Al-Tamimi (Author), Prasanna Vippadapu (Author), Wessa Shenouda (Author), Dixon Thomas (Author) |
---|---|
Format: | Book |
Published: |
Centro de Investigaciones y Publicaciones Farmaceuticas,
2020-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of Anti-Xa Target Attainment with Prophylactic Enoxaparin Dosing Regimens for Venous Thromboembolism Prophylaxis in Morbidly Obese Patients
by: Andrew Sabers, et al.
Published: (2024) -
The use of enoxaparin as venous thromboembolism prophylaxis in bariatric surgery: A retrospective cohort study
by: Esraa Altawil, et al.
Published: (2022) -
Anti-factor Xa levels in obese patients receiving enoxaparin for treatment and prophylaxis indications
by: Tahaineh L, et al.
Published: (2018) -
Optimal Dosing of Enoxaparin in Critically Ill Patients with Venous Thromboembolism
by: Aliya Abdulla, et al.
Published: (2023) -
Current status of venous thromboembolism development during the perioperative period for colorectal cancer, its prevention with enoxaparin, and monitoring methods
by: Aoki J, et al.
Published: (2019)